InMed Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
30 June
InMed Pharmaceuticals Inc. has filed 492 SEC EDGAR filings since 17 Jan 2018

SEC filing history

Showing 1-8 of 8 matching filings.

Per page
25
Current page
1
10-K/A File 001-39685

AMENDMENT NO. 1 TO FORM 10-K

Filing date
24 Oct 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
10-K File 001-39685

ANNUAL REPORT

Filing date
23 Sep 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
10-K File 001-39685

ANNUAL REPORT

Filing date
30 Sep 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
10-K/A File 001-39685

AMENDMENT NO. 1 TO FORM 10-K

Filing date
21 Dec 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
10-K File 001-39685

ANNUAL REPORT

Filing date
29 Sep 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
10-K/A File 001-39685

AMENDMENT NO. 1 TO FORM 10-K

Filing date
28 Sep 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
10-K File 001-39685

ANNUAL REPORT

Filing date
23 Sep 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
10-K File 001-39685

ANNUAL REPORT

Filing date
24 Sep 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .